References
- Wyatt CM, Winston JA, Malvestutto CD, et al., Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007; 21: 2101-3. https://doi.org/10.1097/QAD.0b013e3282ef1bb4
- Schwartz EJ, Szczech LA, Ross MJ, et al., Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol. 2005; 16: 2412-20. https://doi.org/10.1681/ASN.2005040340
- Roling J, Schmid H, Fischereder M, et al., HIV-associated renal diseases and highly active antiretroviral therapyinduced nephropathy. Clin Infect Dis. 2006; 42: 1488-95. https://doi.org/10.1086/503566
- Cheung CY, Wong KM, Lee MP, et al., Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant. 2007; 22: 3186-90. https://doi.org/10.1093/ndt/gfm350
- Bourgoignie JJ, Ortiz-Interian C, Green DF, et al., Race, a cofactor in HIV-1-associated nephropathy. Transplant Proc. 1989; 21: 3899-901.
- Szczech LA. Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management. Clin Infect Dis. 2001; 33: 115-9. https://doi.org/10.1086/320893
- Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int. 1999; 55: 1036-40. https://doi.org/10.1046/j.1523-1755.1999.0550031036.x
- Campbell LJ, Ibrahim F, Fisher M, et al., Spectrum of chronic kidney disease in HIV-infected patients. HIV Med. 2009; 10: 329-36. https://doi.org/10.1111/j.1468-1293.2008.00691.x
- Overton ET, Nurutdinova D, Freeman J, et al., Factors associated with renal dysfunction within an urban HIVinfected cohort in the era of highly active antiretroviral therapy. HIV Med. 2009; 10: 343-50. https://doi.org/10.1111/j.1468-1293.2009.00693.x
- Gupta SK, Eustace JA, Winston JA, et al., Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005; 40: 1559-85. https://doi.org/10.1086/430257
- K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S1-266. https://doi.org/10.1016/S0272-6386(02)70081-4
- Winston JA. Assessing kidney function in HIV infection. AIDS Read. 2007; 17: 257-61,
- New DHHS guidelines for antiretroviral therapy. AIDS Alert. 2010; 25: 21-4.
- Reid A, Stohr W, Walker AS, et al., Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis. 2008; 46: 1271-81. https://doi.org/10.1086/533468
- Szczech LA, Gange SJ, van der Horst C, et al., Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002; 61: 195-202. https://doi.org/10.1046/j.1523-1755.2002.00094.x
- Gardner LI, Holmberg SD, Williamson JM, et al., Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr. 2003; 32: 203-9. https://doi.org/10.1097/00126334-200302010-00013
- Msango L, Downs JA, Kalluvya SE, et al., Renal dysfunction among HIV-infected patients starting antiretroviral therapy. AIDS. 2011; 25: 1421-5. https://doi.org/10.1097/QAD.0b013e328348a4b1
- Szczech LA, Edwards LJ, Sanders LL, et al., Protease inhibitors are associated with a slowed progression of HIVrelated renal diseases. Clin Nephrol. 2002; 57: 336-41. https://doi.org/10.5414/CNP57336
- Pavie J, Scemla A, Bouldouyre MA, et al., Severe acute renal failure in an HIV-infected patient after only 2 weeks of tenofovir-based antiretroviral therapy. AIDS Patient Care STDS. 2011; 25: 457-60. https://doi.org/10.1089/apc.2011.0056
- Rodriguez-Novoa S, Alvarez E, Labarga P, et al., Renal toxicity associated with tenofovir use. Expert Opin Drug Saf. 2010; 9: 545-59. https://doi.org/10.1517/14740331003627458
- Hall AM, Edwards SG, Lapsley M, et al., Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis. Am J Kidney Dis. 2009; 54: 1034-42. https://doi.org/10.1053/j.ajkd.2009.07.012
- Ibrahim F, Naftalin C, Cheserem E, et al., Immunodeficiency and renal impairment are risk factors for HIVassociated acute renal failure. AIDS. 2010; 24: 2239-44. https://doi.org/10.1097/QAD.0b013e32833c85d6
- Dauchy FA, Lawson-Ayayi S, de La Faille R, et al., Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy. Kidney Int. 2011; 80: 302-9. https://doi.org/10.1038/ki.2011.124
- Vigano A, Bedogni G, Manfredini V, et al., Long-term renal safety of tenofovir disoproxil fumarate in vertically HIV-infected children, adolescents and young adults: a 60-month follow-up study. Clin Drug Investig. 2011; 31: 407-15. https://doi.org/10.2165/11590400-000000000-00000